연구동향 분석
박사

분화성 갑상선암 환자에서 치료 후 시행한 I-131 스캔을 이용한 침샘 염증 증상에 대한 예측 연구 : Prediction of risk for symptomatic sialadenitis by post-therapeutic dual I-131 scintigraphy in patient with differentiated thyroid cancer

이상미 2015년

논문상세정보
    • 저자 이상미
    • 형태사항 26 cm
    • 일반주기 지도교수: 배원경
    • 학위논문사항 순천향대학교 일반대학원, Thesis(doctoral)-, 2015. 2, 의학과
    • 발행지 아산
    • 언어 eng
    • 출판년 2015
    • 발행사항 순천향대학교 일반대학원
    유사주제 논문( 0)
인용/피인용

' 분화성 갑상선암 환자에서 치료 후 시행한 I-131 스캔을 이용한 침샘 염증 증상에 대한 예측 연구 : Prediction of risk for symptomatic sialadenitis by post-therapeutic dual I-131 scintigraphy in patient with differentiated thyroid cancer' 의 참고문헌

  • Wu SY, Brown T, Milne N, Eqbert R, Kabok A, Lyons KP, et al. Iodine 131 total body scan-extrathyroidal uptake of radioiodine. Semin Nucl Med. 1986;16:82-4.
  • Verburg FA, H nscheid H, Biko J, Hategan MC, Lassmann M, Kreissl MC, Reiners C, Luster M. Dosimetry-guided high-activity (131)I therapy in patients with advanced differentiated thyroid carcinoma: initial experience. Eur J Nucl Med Mol Imaging 2010;37:896-903
  • Van Nostrand D, Bandaru V, Chennupati S, Wexler J, Kulkarni K, Atkins F, Mete M, Gadwale G. Radiopharmacokinetics of radioiodine in the parotid glands after the administration of lemon juice. Thyroid 2010;20:1113-9
  • Van Nostrand D, Atkins F, Bandaru VV, Chennupati SP, Moreau S, Burman K, Wartofsky L. Salivary gland protection with sialagogues: a case study. Thyroid 2009;19:1005-8
  • Stephens LC, Schultheiss TE, Price RE, Ang KK, Peters LJ. Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer. 1991;67:1539-43.
  • Solans R, Bosch JA, Galofr P, Porta F, Rosell J, Selva-O’Callagan, A, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med. 2001;42:738-43.
  • Raza H, Khan AU, Hameed A, Khan A. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun. 2006;27:495-9.
  • Pettinato C, Spezi E, Nanni C, Grassetto G, Monari F, Allegri V, Civollani S, Cima S, Zagni P, Mazzarotto R, Colletti PM, Rubello D, Fanti S. Pretherapeutic dosimetry in patients affected by metastatic thyroid cancer using 124I PET/CT sequential scans for 131I treatment planning.Clin Nucl Med 2014;39:367-74
  • Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, et al. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med. 2005;46:261-6.
  • Mendoza A, Shaffer B, Karakla D, Mason ME, Elkins D, Goffman TE. Quality of life with well-differentiated thyroid cancer: treatment toxicities and their reduction. Thyroid 2004;14:133-40
  • Mandel SJ, Mandel L. Radioactive iodine and the salivary glands. Thyroid. 2003;13:265-71.
  • Mandel L, Liu F. Salivary gland injury resulting from exposure to radioactive iodine: case reports. J Am Dent Assoc 2007;138:1582-7
  • Malpani BL, Samuel AM, Ray S. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine. Int J Radiat Oncol Biol Phys. 1996;35:535-40.
  • Malpani BL, Samuel AM, Ray S. Differential kinetics of parotid and submandibular gland function as demonstrated by scintigraphic means and its possible implications. Nucl Med Commun. 1995;16:706-9.
  • Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, et al. Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2008;35:1941-59.
  • Liu B, Kuang A, Huang R, Zhao Z, Zeng Y, Wang J, et al. Influence of vitamin C on salivary absorbed dose of I-131in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial. J Nucl Med. 2010;51:618-23.
  • Liu B, Huang R, Kuang A, Zhao Z, Zeng Y, Wang J, et al. Iodine kinetics anddosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer. Med Phys. 2011;38:5412-9.
  • Lee JW, Lee SM, Koh GP, Lee DH. The comparison of I-131 whole-body scans on the third and tenth day after I-131 therapy in patients with well-differentiated thyroid cancer:preliminary report. Ann Nucl Med. 2011;25:439-46.
  • Kodani N, Okuyama C, Aibe N, Matsushima S, Yamazaki H. Utility of additional delayed post-therapeutic I-131 whole-body scanning in patients with thyroid cancer. Clin Nucl Med. 2012;37:264-7.
  • Jeong SY, Kim HW, Lee SW, Ahn BC, Lee J. Salivary gland function five years after a radioiodine ablation in patients with differentiated thyroid cancer: direct comparison of pre and post-ablation scintigraphies and their relation to xerostomia symptoms. Thyroid. 2012. doi:10.1089/thy.2012.0106.
  • Jeong SY, Kim HW, Lee SW, Ahn BC, Lee J. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms. Thyroid 2013;23:609-16
  • Jentzen W, Hoppenbrouwers J, van Leeuwen P, van der Velden D, van de Kolk R, Poeppel TD, Nagarajah J, Brandau W, Bockisch A, Rosenbaum-Krumme S Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET Imaging. J Nucl Med 2014;55:1759-65
  • ICRP publication 106, Radiation dose to patients from radiopharmaceuticals-Addendum 3 to ICRP publication 53. ICRP 2008;38(1-2):1-197
  • Hyer S, Kong A, Pratt B, Harmer C. Salivary gland toxicity after radioiodine therapy for thyroid cancer. Clin Oncol 2007;19:83-6
  • Helman J, Turner RJ, Fox PC, Baum BJ. 99mTc-pertechnetate uptake in parotid acinar cells by the Na+/K+/Cl- co-transport system. J Clin Invest.1987;79:1310-3.
  • Dingle IF, Mishoe AE, Nguyen SA, Overton LJ, Gillespie MB. Salivary morbidity and quality of life following radioactive iodine for well-differentiated thyroid cancer. Otolaryngol Head Neck Surg 2013;148:746-52
  • De La Vieja A, Dohan O, Levy O, Carrasco N. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev. 2000;80:1083-1105.
  • Cohen B, Logothetopoulos JH, Myant NB. Autoradiographic localization of iodine-131 in the salivary glands of the hamster. Nature 1955;176:1268-9
  • Chong A, Song H-C, Min J-J, Jeong S, Ha J-M, Kim J, et al. Improved detection of lung or bone metastases with an I-131 whole body scan on the 7th day after high-dose I-131 therapy in patients with thyroid cancer. Nucl Med Mol Imaging. 2010;44:273-81.
  • Choi JS, Park IS, Kim SK, Lim JY, Kim YM. Morphometric and functional changes of salivary gland dysfunction after radioactive iodine ablation in a murine model. Thyroid 2013;23:1145-51
  • Caglar M, Tuncel M, Alpar R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med. 2002;27:767-71.
  • An YS, Yoon JK, Lee SJ, Song HS, Yoon SH, Jo KS. Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer. Ann Nucl Med. 2013. doi:10.1007/s12149-013-0697-5.
  • An YS, Yoon JK, Lee SJ, Song HS, Yoon SH, Jo KS. Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer. Ann Nucl Med 2013;27:386-91
  • Allweiss P, Braunstein GD, Katz A, Waxman A. Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med. 1984;25:755-8.